Sutro Biopharma Set to Raise $75M Through Common Share Offering
Tuesday, 2 April 2024, 10:36
Sutro Biopharma Announces Underwritten Offering
Sutro Biopharma has successfully priced their underwritten offering, setting the price of common shares at $5.18 each. The company aims to raise around $75 million in gross proceeds through this financial move.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.